Expert Interviews

March 25, 2021

Juan Frias, MD, breaks down results of a post-hoc analysis of the AWARD-11 study examining expanded doses of dulaglutide according to baseline HbA1c levels.

March 23, 2021

Learn more about once-weekly basal insulin Fc from Eli Lilly and Company in this interview with the lead investigator from their phase 2 trial, which was presented at ENDO 2021.

March 09, 2021

Principal investigator of the SURPASS-2 trial discusses the results of the trial and how it informs clinicians on the use of tirzepatide versus currently approved diabetes medications.

March 02, 2021

Published in late February, results of the STEP 1 and STEP 3 trial give clinicians insight into the effects of 2.4 mg subcutaneous semaglutide as an intervention for weight loss in overweight or obese patients ahead of a potential approval in June 2021.

December 21, 2020

Experts in diabetes provide their perspective on various facets of diabetes management including the use of insulin pumps.

December 14, 2020

Learn why one organization prioritizes screening for diabetic retinopathy among patients with diabetes.

December 14, 2020

A discussion centered around optimizing the number of patients with diabetes who receive screening for diabetic retinopathy to ensure the best quality outcomes.

November 27, 2020

Jeffrey Curtis, MD, MS, MPH, details how the perception of biphosphonates has been detrimental to efforts to improve treatment and diagnosis of osteoporosis.

November 24, 2020

An endocrinologist from Brigham and Women’s Hospital discusses the latest in diabetes management.

November 24, 2020

Jeffrey Curtis, MD, MS, MPH, offers his thoughts on the most effective methods to address the underdiagnosis and undertreatment of osteoporosis in older male patients.